A frequent event in benign, atypical, and malignant melanocytic lesions of the skin

American Journal of Dermatopathology

Volumn 25, Issue 5, 2003, Pages 365-370

  Uribe, Pablo ^a   Wistuba, Ignacio I ^a   González, Sergio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Atypical nevi; Benign nevi; BRAF; Melanoma; Mutation

Indexed keywords

ALANINE; GLUTAMIC ACID; THREONINE; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; BRAF GENE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; KERATINOCYTE; MALE; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; MUTATION RATE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE;

EID: 0141565499     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200310000-00001     Document Type: Article

References (25)

1. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol. 1996;34:839-847.
2. Clark WH Jr, Elder DE, Guerry DT, et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol. 1984;15:1147-1165.
3. Sober AJ, Burstein JM. Precursors to skin cancer. Cancer. 1995;75:645-650.
4. Duray PH, Ernstoff MS. Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma. Clinicopathologic experience in a 100-bed hospital. Arch Dermatol. 1987;123:80-84.
5. Rhodes AR, Harrist TJ, Day CL, et al. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol. 1983;9:563-574.
6. Polsky D, Cordon-Cardo C, Houghton A. Molecular biology of melanoma. In: Liotta LA, ed. The Molecular Basis of Cancer. 2nd ed. Philadelphia: Saunders; 2001:385-404.
7. Koh HK, Kligler BE, Lew RA. Sunlight and cutaneous malignant melanoma: evidence for and against causation. Photochem Photobiol. 1990;51:765-779.
8. Hahn WC, Weinberg RA. Rules for making human tumor cells. N Engl J Med. 2002;347:1593-1603.
9. Pollock PM, Trent JM. The genetics of cutaneous melanoma. Clin Lab Med. 2000;20:667-690.
10. Omholt K, Karsberg S, Platz A, et al. Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression. Clin Cancer Res. 2002;8:3468-3474.
11. Peyssonnaux C, Eychene A. The Raf/MEK/ERK pathway: new concepts of activation. Biol Cell. 2001;93:53-62.
12. Avruch J, Khokhlatchev A, Kyriakis JM, et al. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog Horm Res. 2001;56:127-155.
13. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J. 2000;351(Pt 2):289-305.
14. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949-954.
15. Busca R, Abbe P, Mantoux F, et al. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J. 2000;19:2900-2910.
16. Halaban R. The regulation of normal melanocyte proliferation. Pigment Cell Res. 2000;13:4-14.
17. Murphy GF, Mihm MC Jr. Recognition and evaluation of cytological dysplasia in acquired melanocytic nevi. Hum Pathol. 1999;30:506-512.
18. Elwood JM, Gallagher RP. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer. 1998;78:276-280.
19. Wistuba II, Behrens C, Milchgrub S, et al. Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. JAMA. 1998;279:1554-1559.
20. Yuen ST, Davies H, Chan TL, et al. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res. 2002;62:6451-6455.
21. Kowlessur D, Yang XJ, Kaufman S. Further studies of the role of Ser-16 in the regulation of the activity of phenylalanine hydroxylase. Proc Natl Acad Sci U S A. 1995;92:4743-4747.
22. Pollock PM, Harper UL, Hansen KS, et al. High frequency of BRAF mutations in nevi. Nat Genet. 2003;33:19-20.
23. Abdel-Malek ZA. Endocrine factors as effectors of integumental pigmentation. Dermatol Clin. 1988;6:175-183.
24. Tadokoro T, Itami S, Hosokawa K, et al. Human genital melanocytes as androgen target cells. J Invest Dermatol. 1997;109:513-517.
25. Daya-Grosjean L, Dumaz N, Sarasin A. The specificity of p53 mutation spectra in sunlight induced human cancers. J Photochem Photobiol B. 1995;28:115-124.